Back to 
Baker Bros. Advisors LP
Baker Bros. Advisors LPPRPRAX
Showing 0 of 6 quarters
Position history for Baker Bros. Advisors LP's holdings in Praxis Precision Medicines, Inc.
No. Baker Bros. Advisors exited its PRAX (Praxis Precision Medicines) position in Q1 2024. Its Q4 2023 13F listed 131,533 shares worth $2.9M. Baker Bros. Advisors first reported PRAX in Q4 2022 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.